Protalix BioTherapeutics ...

AMEX: PLX · Real-Time Price · USD
1.48
-0.04 (-2.63%)
At close: Aug 15, 2025, 3:59 PM
1.50
1.35%
After-hours: Aug 15, 2025, 05:59 PM EDT

Protalix BioTherapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
53.4M 65.49M 47.64M 38.35M
Cost of Revenue
24.32M 22.98M 19.59M 16.35M
Gross Profit
29.08M 42.51M 28.05M 22M
Operating Income
3.92M 10.46M -13.01M -20.46M
Interest Income
1.3M 1.29M 1.15M 401K
Pretax Income
4.15M 8.57M -14.4M -27.58M
Net Income
2.93M 8.31M -14.93M -27.58M
Selling & General & Admin
12.19M 14.96M 11.71M 12.73M
Research & Development
12.97M 17.09M 29.35M 29.73M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
25.16M 32.05M 41.06M 42.46M
Interest Expense
1.06M 3.18M 2.53M 7.52M
Selling & Marketing Expenses
n/a n/a 25.29M 16.75M
Cost & Expenses
49.48M 55.03M 60.65M 58.81M
Income Tax Expense
1.22M 254K 530K n/a
Shares Outstanding (Basic)
72.53M 67.51M 48.47M 44.14M
Shares Outstanding (Diluted)
81.06M 82.42M 48.47M 44.14M
EPS (Basic)
0.04 0.12 -0.31 -0.62
EPS (Diluted)
0.04 0.10 -0.31 -0.62
EBITDA
6.52M 12.94M -10.78M -18.94M
EBIT
5.22M 11.75M -11.87M -20.06M
Depreciation & Amortization
1.3M 1.19M 1.09M 1.12M